IP Library › Granted Patent US 7,442,546
Granted Patent B2
US 7,442,546 · App. 10/372,303 · Granted Oct 28, 2008

Method of modulating inflammatory response

Assignee: The Regents of the University of Michigan
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,442,546
App. No.
10/372,303
Granted
Oct 28, 2008
Kind
B2
Abstract

A method of immunomodulation by contacting the bodily fluid of a patient with renal tubule cells outside of the kidney.

Claims (8)

1. A method of modulating the levels of at least one inflammatory cytokine in a patient in need thereof, comprising:

contacting, outside of the kidney, at least a portion of the body fluid of the patient with renal tubule cells, wherein the patient in need thereof is suffering from one or more disease selected from the group consisting of, malnutrition, chronic congestive heart failure, inflammatory bowel disease, Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, systemic vasculitis, lupus, Wegener's granulomatosis, polyarteritis nodosa, dermatomyositis, diabetes mellitus Type I, thyroiditis, psoriasis, Guillian Barre syndrome, multiple sclerosis, and atherosclerosis, or other autoimmune disorders.

2. The method of claim 1 , wherein the patient in need thereof is suffering from one or more disease selected from inflammatory bowel disease, Crohn's disease, and ulcerative colitis.

3. The method of claim 1 , wherein the patient in need thereof is suffering from one or more disease selected from rheumatoid arthritis and ankylosing spondylitis.

4. The method of claim 1 , wherein the patient in need thereof is suffering from one or more disease selected from systemic vasculitis, lupus, Wegener's granulomatosis, polyarteritis nodosa, and dermatomyositis.

5. The method of claim 1 , wherein the patient in need thereof is suffering from one or more disease selected from Guillian Barre syndrome and multiple sclerosis.

6. The method of claim 1 , wherein the patient is not afflicted with renal disease.

7. The method of claim 1 , wherein the body fluid is ultrafiltrate of plasma.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2006
From: HUMES, H. DAVID
To: REGENTS OF THE UNIVERSITY OF MICHIGAN, THE
Reel/Frame 017889/0185 →
Continuity (2)
Provisional Application 6036412800 · Mar 15, 2002
Related Publication 20030223969A1 · Dec 4, 2003